Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.35 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.32 |
| ▸ | PAM | P19021 | 2/20 | 0.32 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.31 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 2/20 | 0.31 |
| ▸ | PPARD | Q03181 | 2/20 | 0.31 |
| ▸ | PPARA | Q07869 | 2/20 | 0.31 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.31 |
| ▸ | TLR2 | O60603 | 1/20 | 0.31 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23111822 | 0.98 | TSHR (0.39) | LMNATSHRNFKB1PMP22SLC22A6 | |
| SCHEMBL6767253 | 0.97 | TSHR (0.40) | LMNATSHRNFKB1PMP22SLC22A6 | |
| SCHEMBL23355066 | 0.90 | KDM2A (0.33) | LMNAFOLH1 | |
| SCHEMBL2019309 | 0.84 | LMNA (0.41) | LMNATSHRNFKB1PMP22SLC22A6 | |
| SCHEMBL3223948 | 0.83 | TSHR (0.43) | LMNATSHRNFKB1PMP22SLC22A6 | |
| SCHEMBL7895528 | 0.81 | TSHR (0.44) | LMNATSHRNFKB1PMP22SLC22A6 | |
| SCHEMBL1580299 | 0.78 | TSHR (0.35) | LMNATSHRNFKB1PMP22SLC22A6 | |
| SCHEMBL1509902 | 0.77 | TSHR (0.35) | LMNATSHRNFKB1PMP22SLC22A6 | |
| SCHEMBL9980489 | 0.77 | NAAA (0.35) | ALDH1A1 | |
| SCHEMBL5527309 | 0.76 | TSHR (0.33) | LMNATSHRNFKB1PMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4216929-A1 | SUSTAINED RELEASE BIODEGRADABLE INTRACANALICULAR INSERTS COMPRISING A HYDROGEL AND AN ACTIVE AGENT | Ocular Therapeutix, Inc. (US) | 2023-08-02 | — | — | EP | disclosed |
| EP-4203996-A1 | PENTAVALENT VACCINE AGAINST NEISSERIA MENINGITIDIS COMPRISING A SYNTHETIC MEN A ANTIGEN | GlaxoSmithKline Biologicals SA (BE) | 2023-07-05 | — | — | EP | disclosed |
| EP-4009857-A1 | BIOERODIBLE CROSS-LINKED HYDROGEL IMPLANTS AND RELATED METHODS OF USE | DOSE Medical Corporation (US) | 2022-06-15 | — | — | EP | disclosed |
| WO-2022043238-A1 | PENTAVALENT VACCINE AGAINST NEISSERIA MENINGITIDIS COMPRISING A SYNTHETIC MEN A ANTIGEN | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2022-03-03 | — | — | WO | disclosed |
| EP-3934696-A1 | CARBOCYCLIC DERIVATIVES AND CONJUGATED DERIVATIVES THEREOF, AND THEIR USE IN VACCINES | GlaxoSmithKline Biologicals S.A. (BE) | 2022-01-12 | — | — | EP | disclosed |
| EP-3793622-A1 | EMBOLIC COMPOSITIONS AND METHODS | Incept, LLC (US) | 2021-03-24 | — | — | EP | disclosed |
| WO-2021026214-A1 | BIOERODIBLE CROSS-LINKED HYDROGEL IMPLANTS AND RELATED METHODS OF USE | DOSE MEDICAL CORPORATION (US) | 2021-02-11 | — | — | WO | disclosed |
| WO-2020243602-A1 | BIOERODIBLE CROSS-LINKED HYDROGEL IMPLANTS AND RELATED METHODS OF USE | DOSE MEDICAL CORPORATION (US) | 2020-12-03 | — | — | WO | disclosed |
| WO-2020182635-A1 | CARBOCYCLIC DERIVATIVES AND CONJUGATED DERIVATIVES THEREOF, AND THEIR USE IN VACCINES | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2020-09-17 | — | — | WO | disclosed |
| EP-3380077-A1 | SHAPE CHANGING DRUG DELIVERY DEVICES AND METHODS | Incept, LLC (US) | 2018-10-03 | — | — | EP | disclosed |
| EP-3294212-A1 | DRUG DELIVERY FROM HYDROGELS | Incept, LLC (US) | 2018-03-21 | — | — | EP | disclosed |
| EP-3229779-A1 | HYDROGEL DRUG DELIVERY IMPLANTS | Incept, LLC (US) | 2017-10-18 | — | — | EP | disclosed |
| WO-2017091749-A1 | SHAPE CHANGING DRUG DELIVERY DEVICES AND METHODS | INCEPT, LLC (US) | 2017-06-01 | — | — | WO | disclosed |
| WO-2016183296-A1 | DRUG DELIVERY FROM HYDROGELS | INCEPT, LLC (US) | 2016-11-17 | — | — | WO | disclosed |
| WO-2016094646-A1 | HYDROGEL DRUG DELIVERY IMPLANTS | INCEPT, LLC (US) | 2016-06-16 | — | — | WO | disclosed |
| EP-2787973-A1 | MEDICAL ORGANOGEL PROCESSES AND COMPOSITIONS | INCEPT LLC (US) | 2014-10-15 | — | — | EP | disclosed |
| WO-2013086015-A1 | MEDICAL ORGANOGEL PROCESSES AND COMPOSITIONS | INCEPT, LLC (US) | 2013-06-13 | — | — | WO | disclosed |
| EP-1979084-A2 | SYNTHESIS AND USE OF CROSS-LINKED HYDROPHILIC HOLLOW SPHERES FOR ENCAPSULATING HYDROPHILIC CARGO | APPLERA CORPORATION (US) | 2008-10-15 | — | — | EP | disclosed |
| WO-2007102929-A2 | SYNTHESIS AND USE OF CROSS-LINKED HYDROPHILIC HOLLOW SPHERES FOR ENCAPSULATING HYDROPHILIC CARGO | APPLERA CORPORATION (US) | 2007-09-13 | — | — | WO | disclosed |